Amsterdam UMC Becomes First to Perform Cardiac Catheter Ablation in Diagnostic MRI Lab

23 June 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) is pleased to announce the first procedure using the Company’s products in a traditional diagnostic MRI lab have been performed at the Amsterdam University Medical Center. The procedure was successfully performed by Dr. Marco Götte, MR imaging cardiologist, and Dr. Cor Allaart, electrophysiologist (

“We are the third medical center in Europe to apply this new MRI intervention technique clinically in the treatment of interventional cardiac arrhythmias,” says Götte. “The MRI-led treatment of cardiac arrythmias is a low-risk procedure in which we combine two methods. Namely, the existing catheter ablation procedure for the treatment of heart arrhythmias and the use of the MRI scanner instead of an X-ray machine,” explains Götte. “Performing this procedure under MRI allows for direct peri-procedure visualization of ablation lesions. This has the potential to improve clinical results substantially”, according to Dr. Götte.

In addition, Imricor supported Dr. Götte and his team to develop workflows suitable for performing these procedures in a diagnostic MRI lab. These workflows include patient safety protocols to ensure appropriate care in the MRI environment.

“This achievement marks the first time our products have been commercially used in a traditional diagnostic MRI lab environment. What this represents is an opportunity for hospitals who want to utilize an existing lab or are in the process of building their own interventional cardiac MRI lab and want to begin immediately,” stated Nick Twohy, Director of Marketing for Imricor.

~ ~ ~ ~ ~
About Imricor